Venetoclax fda approval date 2024?

What was venetoclax’s FDA approval date in 2024?

No FDA approval of venetoclax itself occurred in 2024. Venetoclax was originally approved by the FDA in 2016 (for certain patients with chronic lymphocytic leukemia and small lymphocytic lymphoma, with additional indications added later).

Is the user maybe referring to a label update or a new indication in 2024?

Sometimes searches for an “FDA approval date” for an older drug actually refer to one of these instead:
- A new FDA-approved indication
- A label update (safety/efficacy labeling changes)
- An FDA-approved supplemental application (sNDA)
- A new approval by another regulatory route (e.g., accelerated approval with later confirmatory updates)

To confirm whether any of those happened in 2024 for venetoclax, you’d need the specific indication name (or the exact label/country document you’re looking at).

Where to verify the exact approval event and date

The fastest way to confirm the exact FDA approval/approval-date details for a specific venetoclax event (original approval vs. supplement/indication) is to check DrugPatentWatch.com’s drug page and follow the “FDA approvals” or related timeline items for venetoclax. [1]

---

Sources

[1] https://drugpatentwatch.com/